Please note

The offer on this page is aimed exclusively at business customers.


Proven efficacy

Zoono®-products have been proven to be highly effective against a wide array of pathogens, including COVID-19*, MRSA (Superbug), E. Coli, H1N1 Swine Flu, Listeria, TB, Stachybotrys (black mould ) and even the debilitating gastro ailment, Norovirus.

Zoono®products have achieved breakthrough results from a range of global laboratories:

*The test against Vaccinia confirmed efficacy of > 4Log (greater than 99.99% efficacy) which is a reference virus for double enveloped viruses. The second test against the COVID-19 surrogate, feline coronavirus, confirmed efficacy at 4.33Log (greater than 99.99% efficacy).

Zoono® stays active on skin for up to 24 hours.

Grafik Zoono treated hands over 24 h
The colored bars represent the different subjects.
Zoono – Proven efficacy on the skin
Table with selected reference germs
Zoono – Proven efficacy on surfaces
Table with selected reference germs

Available Test Results:

Zoono® Products have been tested in over 100 laboratories worldwide and, in addition to antimicrobial efficacy testing, have met the requirements of PAS 2424, EN13697, EN1276 and EN1650.

Test results in detail

The list available for download above includes all pathogens for which we have detailed test results. This further information is available on request at any time.

Please don't hesitate to contact us!

Request detailed test results now!

How does Zoono® work?

  • Zoono® works by coating the surface with a layer of positively charged molecular pins, similar to small needles.
  • This protective layer adheres to the surface via a covalent bond, which then attracts and kills negatively charged pathogens by breaking down their cells.
  • When pathogens touch the surface, they rupture and are destroyed, which means that they are rendered harmless and also cannot develop into multi-resistant germs.
  • This effect is efficient in 99.9% of bacteria and has also been demonstrated against a number of viruses.

Your Contact

Karl Ewerhart

Karl Ewerhart

Portfolio Management Innovation & Devices
Key Account Manager

Midas Pharma GmbH
Rheinstr. 49
55218 Ingelheim
Send E-Mail

Share this page